T hrombosis of the portal venous system has been reported as a possible cause of death after splenectomy. This complication was considered as an uncommon complication. 1 However, with the improvement in diagnostic modalities and the increased interest in this disease entity, it is becoming apparent that the incidence of portal or splenic vein thrombosis (PSVT) may be greater than clinically appreciated and may, at times, be asymptomatic. [2] [3] [4] [5] [6] Rattner et al 2 reported 6 patients in more than 1000 splenectomies, and recent reports on symptomatic PSVT demonstrated the incidence between 1.1% (4 of 350) and 8% (8 of 101). [5] [6] [7] However, since the above reports were all retrospective case log analyses, the actual incidence of PSVT after elective splenectomy has not been elucidated. In retrospective studies of postoperative imaging surveillance for detection of PSVT, Petit et al 3 reported 13 of 119 patients (10.9%) developed PSVT, 7 of whom were asymptomatic. Loring et al 8 reported 12 of 123 patients (9.8%) had PSVT, 3 of whom were asymptomatic.
To determine the true incidence of PSVT after splenectomy, prospective studies have been conducted with ultrasonography. 4, 9, 10 Skarsgard et al 9 presented one (6.3%) asymptomatic PSVT among 16 consecutive pediatric patients with hematologic diseases. Chaffanjon et al 4 reported one symptomatic and 3 asymptomatic PSVT (total 6.7%) in a prospective series of 60 consecutive splenectomies for hematologic disorders. Hassn et al 10 reported 5 patients (10%) with PSVT (one asymptomatic) in 50 elective splenectomy. Taken together, the incidence of postsplenectomy PSVT is about 5% to 10% according to these retrospective and prospective studies.
However, since these three prospective studies showed the incidence only after conventional open splenectomy (OS), the impact of laparoscopic splenectomy (LS) on the incidence of PSVT is still undetermined. Because LS is gaining wide acceptance as a safe, effective alternative to OS in the treatment of hematologic disorders, 11, 12 it is important to determine the actual incidence of PSVT after LS. Only 2 of 545 patients with suspicious PSVT symptoms have been reported based on literature review of recent reports on the complications of LS, and these studies concluded that LS is safe and efficacious for benign and malignant hematologic diseases. [13] [14] [15] [16] [17] [18] [19] The symptoms in these reported patients were fever of unknown origin and intestinal infarction, but the diagnosis of PSVT was not made. In contrast, Winslow et al 6 emphasized that PSVT does occur after LS. To our knowledge, 6 cases with post-LS PSVT have been reported so far. 20 -25 The aim of this prospective study was to determine the actual incidence of PSVT after LS using contrast-enhanced computed tomography (CT) and to determine the treatment outcome of PSVT.
PATIENTS AND METHODS

Patient Eligibility and Population
Patients 18 years of age or older were enrolled in the study if they were scheduled for LS, hand-assisted LS (HALS), or OS. Before entry into the study, informed consent was obtained from all patients. Patients were excluded from the study if they had history of venous thromboembolism, had hypersensitivity to the intravenous contrast media, or had renal dysfunction. Between April 2001 and June 2003, 24 consecutive LS or HALS were performed at the Department of Surgery and Clinical Oncology, Osaka University Medical Hospital. Of these patients, 2 patients were excluded from this study because of hypersensitivity and renal dysfunction. Thus, 22 patients were entered into the study (LS group). HALS was performed in 3 patients with hypersplenism and lymphangioma, because of splenomegaly.
For comparison of OS versus LS, patients who elected to undergo OS were recruited to this study. During the same period, 19 patients with gastric cancer, 1 with rectal cancer, and 1 with ovarian cancer were recruited as open splenectomy group (OS group). The underlying diseases were gastric cancer (19 patients), splenic cyst, and metastatic splenic tumor originating from ovarian cancer. For the patients with gastric cancer, the indication for splenectomy was en bloc node dissection with total gastrectomy. Patients with pancreaticosplenectomy were not included in this study. One patient with splenic tumor underwent splenectomy for histologic diagnosis, and the operation was conducted during surgery for resection of rectal cancer. The diagnosis was a solitary splenic cyst. The other patient with metastatic splenic tumor underwent splenectomy in association with bilateral oophorectomy with radical lymph node dissection. Intermittent pneumatic foot pump was used for perioperative prophylaxis of deep venous thrombosis until full ambulation, but no anticoagulant was used for patients of both the LS and OS groups. Table  1 lists the clinical characteristics of our patients.
Operative Technique for Laparoscopic Splenectomy
After induction of general anesthesia, patients were placed in the right semilateral position. At the beginning of the procedure, patients were adjusted to a horizontal position by rotation of the table to the right side. The first trocar (12 mm) was inserted below the left costal margin, at the level of the midaxillary line, where the laparoscope would be placed. The abdomen was then insufflated (10 -12 mm Hg) and three additional trocars were inserted under direct laparoscopic vision: 1) subxyphoid (5 mm); 2) subcostal left flank (5 mm); and 3) subcostal area between the first port and the left flank (12 mm) . First, a thorough inspection of the abdomen for accessory spleen was made. The inferior pole of the spleen was mobilized by dissecting the splenocolic ligament. Short gastric vessels were then controlled with a harmonic scalpel and exposure of the splenic hilum was achieved. Once the anterior aspect of the hilum was exposed, the left gutter was dissected and the spleen was separated from the kidney and diaphragm. At this point, the spleen remains attached almost entirely by the vascular supply, and the gap between the splenic hilum and tail of the pancreas was enlarged. The splenic hilar vessels were divided with an endoscopic vascular stapler. Extraction of the spleen was accomplished by morcellation within EndoCatche II (USSC, Norwalk, CT). Special attention was paid to avoid splenic fracture and intraabdominal spillage of splenocytes to prevent the development of splenosis. For HALS, a skin incision for the hand insertion was made in the right subcostal area. The procedure for splenectomy was similar to that described for LS and the splenic hilar vessels were also divided with an endoscopic vascular stapler.
Operative Technique for Open Splenectomy
All OSs were performed through a midline incision. For patients with gastric cancer, since the indication of splenectomy was en bloc node dissection, the spleen was resected with the stomach without dissection of the gastrosplenic ligament. The vessels at splenic hilum were ligated and divided at the tail of the pancreas. For the patients with splenic tumor, only the spleen was excised, in addition to the rectal cancer or ovarian cancer operation. The procedure for the division of splenic hilum was similar to that used in patients with gastric cancer.
Detection and Diagnosis of PSVT Using Contrast-Enhanced CT
All patients underwent preoperative and postoperative helical CT. The diagnosis of PSVT was made by a radiologist and a surgeon based on the detection of unenhanced region in the dilated splenoportal system, where no abnormality was found in the preoperative CT. The extent of occlusion of the portal vein, splenic vein, and superior mesenteric vein was precisely defined. PSVT was divided according to the location of the thrombus. The inferior mesenteric vein (IMV) was identified, and thrombus formation in the splenic vein distal to the junction of IMV was diagnosed as distal splenic vein thrombosis (dSVT). Thrombi between the portal vein and IMV were diagnosed as proximal SVT (pSVT). In case of IMV directed towards the superior mesenteric vein (SMV), SVT was identified as dSVT. Portal vein thrombi were divided into intrahepatic and extrahepatic thrombosis (iPVT and ePVT, respectively). Portal vein branches involved with thrombus were also determined. Two patients in the LS group and 2 patients in the OS group developed only dSVT. Those
Laboratory Tests
Since prothrombotic disorders are commonly associated with PSVT, 26 blood samples were taken from all patients of the LS group, except 2 with liver cirrhosis and hypersplenism, to screen for thrombophilia, such as antithrombin III (AT-III) deficiency, protein C deficiency, protein S deficiency, and dysplasminogenemia. In addition, screening for antiphospholipid syndrome (lupus anticoagulant and ␤2 glycoprotein) was performed. Complete blood count, transaminases (AST, ALT), serum amylase, C-reactive protein (CRP), thrombin-AT-III complex (TAT), and D-dimer (DD) were examined perioperatively (before operation, on postoperative days 1, 2, 4 Ϯ 1, and 7 Ϯ 1).
Statistical Analysis
Continuous data are expressed as mean Ϯ SD, unless specifically noted. Statistical analysis was performed using the 2 test or Fisher exact test for categorical data and Mann-Whitney U test for nonparametric data. Chronologic changes in the laboratory data were analyzed by analysis of variance for repeated measures. All statistical analyses were completed using StatView 5.0J (SAS Institute Inc., NC). A P value of Ͻ0.05 was considered significant.
RESULTS
Incidence of PSVT and Clinical Course After LS
Twelve (55%, 95% confidence interval, 32.2%-75.6%) of 22 patients who underwent postoperative CT (between 3 and 23 postoperative days ͓POD͔, median; 6.5 POD) developed PSVT after LS (Table 2) . Specifically, 1 patient (case 2) had proximal and distal SVT, 4 patients (cases 1, 5, 10, and 12) developed iPVT and dSVT, 4 patients (cases 4, 7, 9, and 11) had iPVT alone, 1 patient (case 3) developed ePVT, SMVT, pSVT, and dSVT, 1 patient (case 6) had ePVT, pSVT, and dSVT, and 1 patient developed iPVT, pSVT, and dSVT (case 8). Figure 1 shows schematically the anatomic extension of the thrombus in each patient. The mean age of patients with and without PSVT was 44.0 years (17.8 years) and 48.2 years (19.2 years), respectively ( Table 3) . Nine of 13 patients with idiopathic thrombocytopenic purpura and 1 patient with splenic cyst did not develop PSVT, while all other patients developed PSVT. All 12 patients with PSVT received anticoagulant therapy ( Table 2 ). Intravenous infusion or subcutaneous heparin was used for cases 1, 2, 4, and 5 (adjusted individually, aiming at 1.5-to 2-fold prolongation of the pretreatment activated partial thromboplastin time). All 12 patients received anticoagulant therapy with warfarin; the dose was adjusted to achieve an international normalized ratio (INR) between 1.5 and 2.0 until resolution of PSVT. Follow-up studies (performed between 53 and 161 POD; median, 93 POD) demonstrated complete resolution of PSVT in 9 of 12 patients and improvement in the other 3 patients. One patient (case 1) had only dSVT, and 1 patient (case 8) had iPVT and dSVT, and the other patient (case 3) had ePVT, SMVT, and dSVT. Case 3 received oral anticoagulant for 183 POD until complete resolution of both ePVT and SMVT. All pSVT and 8 of 9 iPVT showed complete resolution (Fig. 1) . The resolution rate of dSVT, pSVT, and iPVT was 5 of 8 (62.5%), 4 of 4 (100%), and 8 of 9 (88.9%), respectively. Four patients (33.3%) had fever greater than 38°C, and 2 patients (16.7%) had abdominal pain postoperatively, but none had ascites or peritoneal edema. Eight patients (66.7%) were asymptomatic. Five patients had abnormal AST or ALT values after operation. Case 8 with marked splenomegaly had pancreatic injury, which needed 15-day drainage. The other patients with PSVT did not require treatment of major postoperative complications except anticoagulant therapy.
Incidence of PSVT and Clinical Course After OS
As shown in Table 1 , patients who underwent OS were older, and their operative time and blood loss were significantly greater than those who had LS. Four (19%, 95% confidence interval, 5.4%-41.9%) of 21 patients who underwent postoperative CT (between 4 and 12 POD; median, 7 POD) developed PSVT after OS (Table 4 ), and all these 4 patients had gastric cancer. Specifically, 1 patient (case 1) had iPV alone, 2 patients (cases 2 and 3) had iPVT and dSVT, and the other patient (case 4) had ePVT, SMVT, pSVT, and dSVT. Figure 2 is a schematic drawing of the anatomic extension of thrombosis in each patient. Follow-up studies were performed in 3 patients on 83, 120, and 244 POD. These studies showed residual iPVT in case 1. In case 2, PSVT could not be evaluated because of multiple liver metastases. Anticoagulant therapy was administered for case 4, in the form of intravenous infusion or subcutaneous injection of heparin and warfarin. Three patients developed fever higher than 38°C, and 1 patient complained of abdominal pain postoperatively, but none had ascites or peritoneal edema. The incidence of PSVT after OS was significantly lower than that after LS (P ϭ 0.03).
Incidence of Prothrombotic Disorders
Of 19 patients who participated in the screening for prothrombotic disorders, no dysplasminogenemia, AT-III, protein C, and protein S deficiencies were detected. Only 1 patient (case 2) who developed pSVT and dSVT had abnormal lupus anticoagulant, suggesting an association of antiphospholipid syndrome. Two patients with liver cirrhosis and hypersplenism who did not provide blood samples for screening for thrombophilia had PSVT. Nine of 12 patients with post-LS PSVT had no prothrombotic disorders, suggesting that PSVT can occur without primary deficiencies in natural coagulation inhibitors.
Factors Associated With PSVT
In an attempt to identify clinical and laboratory parameters that could predict the occurrence of postsplenectomy thrombosis, patients with PSVT were compared with those without such complication, with respect to age, sex, diagnosis, operation time, blood loss, splenic weight, preoperative and postoperative platelet count, white blood cell count, CRP, TAT, and DD. Age, sex, and diagnosis did not differ between the 2 groups (Table 3 ). Patients with PSVT had significantly heavier splenic weight (g) (median, 216 g; interquartile range, 167 g) than those without PSVT (median, 82 g; interquartile range, 67 g), suggesting that a large splenic mass is a possible risk factor for postsplenectomy PSVT, but we did not find difference in operation time (median, 124 minutes vs. 111 minutes) and blood loss (25 mL vs. 40 mL) between the two groups. Figure 3 shows serial changes in platelet count, white blood cell count, and CRP. Platelet count, white blood cell count, and CRP in patients with PSVT were greater than in those without PSVT, but the difference was not significant. We also did not find differences in preoperative and postoperative TAT and DD values.
DISCUSSION
In several prospective studies, the incidence of PSVT determined by ultrasonography ranged from 6.3% to 10%. 4, 9, 10 In the present study, the incidence of PSVT after elective laparoscopic splenectomy was 55% as determined by abdominal CT with intravenous contrast. The incidence was markedly higher than that reported in previous studies, and also significantly higher than that associated with open splenectomy, even though the patients in the OS group had known risk factors for thromboembolism, ie, old age and malignancy. The usefulness of CT for the diagnosis of PSVT after splenectomy has been emphasized previously. [2] [3] [4] 6, 8, 27 In the presence of bowel distention or morbid obesity, ultrasonography is often limited in detecting thrombosis 3, 4, 8 ; on the other hand, CT can provide objective images and exclude other intraabdominal complications. 6 CT is comparable to ultrasonography in evaluating portal veins. 28, 29 Difference in the modality used to examine PSVT might explain the differences in the incidence of PSVT determined in the above previous studies and the present investigation. By using ultrasonography, Skarsgard et al 9 identified left portal vein thrombosis in asymptomatic patients, and Chaffanjon et al 4 diagnosed 3 cases of portal vein thrombosis of the main, right, and left branches, and one mesenteric thrombosis. Four other cases with PSVT were diagnosed by ultrasonography, with the thrombus in the main or major branches, not segmental branches, 20, 24, 25, 30 suggesting that patients with only segmental portal vein thrombosis or distal splenic vein thrombosis cannot be diagnosed by ultrasonography. In our series, 5 patients (22.7%; cases 1, 3, 5, 6, and 10) had PSVT in major branches or the main portal vein, and the other 7 patients might have been diagnosed as normal by ultrasonography.
The fact that the date of onset of PSVT after splenectomy is unclear and we performed CT scanning once after splenectomy between 3 and 23 postoperative days might also influence the true incidence of PSVT. PSVT was diagnosed more than 1 year after splenectomy in some cases. 2, 5 However, in most cases, PSVT was diagnosed on 2 to 22 days after open splenectomy, 2, 5, 6, 9 and in patients with laparoscopic splenectomy the intervals between diagnosis and splenectomy were 4 to 14 days. 20 -24 The date of postoperative CT scanning in our study is comparable to the reported dates of PSVT diagnosis, and Chaffanjon et al 4 demonstrated that no thrombus resolution was found until POD 30 by prospective study, suggesting that the incidence of PSVT is unlikely to be altered by performing CT once after splenectomy between 3 and 23 days postoperatively.
A number of investigators have recommended the use of postoperative prophylaxis such as heparin for high-risk patients. 6, 9 It is possible that the lack of heparin use in our study might have contributed to the remarkably high incidence of PSVT. However, previous studies reported that 7 of 9 PSVT patients 5 and 5 of 8 patients 6 developed PSVT despite receiving prophylactic anticoagulation. Chaffanjon et al 4 reported that 6.7% developed PSVT even after using low molecular weight heparin, and Skarsgard et al 9 reported that 6.3% developed PSVT without any prophylaxis, suggesting that the role of prophylaxis remains uncertain. Our finding of the significantly higher incidence of PSVT in LS group compared with the OS group, even though both groups did not receive thrombosis prophylaxis implies that there must be some other factors that could contribute to the high incidence of PSVT in the LS group.
A possible reason for the high incidence of PSVT is the surgical technique itself. The 2 major differences in the operative technique between laparoscopic and open splenectomy in this study were pneumoperitoneum and ligation of splenic hilar vessels. In the OS group, splenic hilar vessels were ligated conventionally, while these vessels were divided with an endoscopic vascular stapler in the LS group. Previous studies showed that pneumoperitoneum may cause a hypercoagulable state during laparoscopic surgery. 31, 32 Changes in intraabdominal pressure during splenectomy decrease portal vein blood flow and induce stasis. 33, 34 Both stasis of venous flow and resulting congested coagulation factors may induce PSVT. Baixauli et al 35 reported PSVT after laparoscopic colectomy without known risk factor for venous thrombosis, and stressed the importance of pneumoperitoneum-induced changes in hemodynamic and coagulation states. In patients with splenomegaly, the large stump of splenic vein causes blood turbulence, which in turn can result in a local increase in coagulability and enhance thrombus formation. 2, 6 In our series, spleen weight of patients with PSVT was significantly heavier than that of patients without PSVT, suggesting that spleen weight is a possible predictor of postoperative PSVT. Differences in the shape of the stump may also affect the hemodynamic and coagulation states. In the LS group, splenic hilar vessels were ligated extensively with endoscopic stapler, which results in a reduction of circulation around the ligated area, and may therefore enhance venous stasis at the very end of the stump.
Broe et al 36 demonstrated in a postmortem study that the thrombus originated in and extended from the distal splenic vein into the mesenteric and portal vein. This has been accepted as the key pathogenic event. 2 In our series, proximal propagation of thrombus was found in cases 2, 3 and 6; however, we also find 4 patients with isolated iPVT (cases 4, 7, 9, 11), and 5 patients with isolated iPVT and dSVT (cases 1, 5, 8, 10, 12). Majority of patients had right-side iPVT. Our speculation for the occurrence of iPVT is embolism of the thrombus originated in the distal splenic vein by the inferior mesenteric venous flow. Therefore, iPVT is likely to occur on the right side of the hepatic portal system because the right side of the portal venous flow is greater than the left one.
In this prospective study including preoperative and sequential postoperative imaging, routine postoperative CT imaging clearly demonstrated the occurrence of PSVT and the effect of anticoagulant therapy. Furthermore, initiation and termination of anticoagulant therapy were effectively performed based on CT images. Postoperative surveillance has been recommended for early diagnosis of PSVT, but its clinical use is still debatable. 3, 8 Since the safety of LS has been well recognized in the clinical setting, [13] [14] [15] [16] [17] [18] [19] routine surveillance imaging for PSVT does not seem warranted. Postoperative surveillance must be confined to patients at high risk for PSVT, and anticoagulant therapy should be provided for patients with poor prognosis.
We found that spleen weight was a possible predictor of postoperative PSVT. Our results also showed that the frequency of PSVT was in part dependent on the underlying disease. All patients with hemolytic anemia, malignant lymphoma, lymphangioma, and hypersplenism developed PSVT, as has been reported previously. 5, 6, 37 Therefore, patients with splenomegaly, hemolytic anemia, malignant lymphoma, lymphangioma, and hypersplenism are at high risk of postsplenectomy PSVT and require close surveillance. In addition, for patients who develop leukocytosis, CRP elevation, and thrombocytosis during the postoperative period, they should be suspected of having PSVT and CT with contrast is recommended.
Loring et al 8 reported 2 cases with complete resolution and 1 case with partial resolution of 7 untreated PSVT patients, and Skarsgard et al 9 reported 2 cases with PSVT whose thrombosis resolved spontaneously without treatment. These 5 cases had SVT and iPVT without thrombus propagation into the SMV. On the other hand, in a disastrous case, autopsy revealed propagation of the thrombus from the remaining splenic vein into the SMV with resultant bowel infarction. 2, 36 Involvement of SMV is associated with poor prognosis, while involvement of portal vein may be considered as a less serious condition. Gertsch et al 38 also reported poor prognosis with complete obstruction of SMV, and good prognosis with isolated portal vein thrombosis. Therefore, patients with SMVT should be treated without delay; however, whether all other patients not having SMVT require treatment should be determined.
The treatment used for PSVT in the present study was anticoagulation with heparin and/or warfarin. All 12 patients with PSVT received low-intensity warfarin therapy, which was designed to maintain INR between 1.5 and 2.0 for a median period of about 3 months. The usefulness of lowintensity warfarin therapy has been reported for the prevention of recurrent venous thromboembolism with low morbidity. 39 No thrombus progression was noted, and all portal, mesenteric, and proximal splenic vein thrombosis completely resolved within 6 months. One of the reasons for the effectiveness of low intensity warfarin therapy is the low incidence of prothrombotic disorders in our series. In contrast, a high prevalence of prothrombotic disorders, such as antiphospholipid syndrome, protein C, protein S, plasminogen, and antithrombin III deficiency, has been reported in patients with idiopathic PSVT (not after splenectomy). 26, 40 For the latter group of patients, lifetime anticoagulation is often required.
CONCLUSION
We have demonstrated in the present study that PSVT is a common complication after laparoscopic splenectomy and can occur without any prothrombotic disorders. Especially, patients with splenomegaly were at high risk for PSVT. PSVT was safely treated by prompt anticoagulant therapy dependent on the CT results. Although our prospective study clearly demonstrated the usefulness of routine CT surveillance for the detection and treatment of PSVT, further studies are necessary to confirm the need for routine surveillance imaging, thrombotic prophylaxis, and treatment in the management of postsplenectomy PSVT.
